Understanding Endocrinology Data on DocTransparency

Understanding Endocrinology Data on DocTransparency

What Endocrinologists Do

Endocrinologists specialize in the endocrine system — the glands and hormones that regulate metabolism, growth, reproduction, and other body functions. Common conditions include type 1 and type 2 diabetes, thyroid disorders (hypothyroidism, hyperthyroidism, thyroid nodules), osteoporosis, adrenal disorders, pituitary tumors, and polycystic ovarian syndrome. Diabetes management is the single largest component of most endocrinology practices.

Common Procedures in Medicare Data

  • Office visits — The dominant billing category; most endocrinology care is cognitive and consultative
  • Thyroid ultrasound — Imaging of the thyroid gland to evaluate nodules
  • Thyroid fine needle aspiration (FNA) — Biopsy of thyroid nodules to rule out cancer
  • Continuous glucose monitoring (CGM) setup and management — Device-based diabetes monitoring
  • Bone density testing (DEXA scan) — Ordered or interpreted for osteoporosis evaluation
  • Insulin pump management — Programming and management of insulin delivery devices

What Normal Volume Looks Like

Endocrinology is primarily a non-procedural specialty. Medicare data will show relatively modest procedure counts alongside substantial office visit billing. Endocrinologists managing large diabetes populations may have high patient counts with lower per-patient procedural intensity. The presence or absence of thyroid ultrasound and FNA in the billing data indicates whether the physician does in-office procedures or refers these out.

Pharma Payments in Endocrinology

Pharmaceutical payments in endocrinology are largely driven by diabetes drug companies. Manufacturers of GLP-1 receptor agonists, SGLT-2 inhibitors, insulin products, and other diabetes medications invest heavily in speaker bureaus and consulting arrangements with endocrinologists. Osteoporosis drug companies are another significant source. Given the scale of the diabetes drug market, endocrinologists who manage large diabetes panels often have notable pharma payment histories.

Questions to Ask Your Endocrinologist

  • Do you have financial relationships with the pharmaceutical companies whose diabetes or thyroid medications you prescribe?
  • For a thyroid nodule: what size and characteristics would indicate that a biopsy is necessary?
  • Is the diabetes medication you are recommending the most cost-effective option, or is there a less expensive alternative with similar outcomes?
Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →